Press Release ArriVent BioPharma Reports Second Quarter 2026 Financial Results ArriVent BioPharma, Inc. · Aug 12
Press Release Perma-Fix Reports Second Quarter 2026 Results, Award of Hanford Master IDIQ Subcontract and Commencement of DFLAW Waste Receipts Perma-Fix Environmental Services, Inc · Aug 12
Press Release BioStem Technologies Reports Second Quarter 2026 Financial Results BioStem Technologies, Inc. · Aug 12
Press Release SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates SeaStar Medical · Aug 12
Press Release Byrna Appoints Retired U.S. Army Brigadier General Rose Lopez Keravuori to Board of Directors Byrna Technologies, Inc. · Aug 12
Press Release Allogene Therapeutics Reports Second Quarter 2026 Financial Results and Business Update Allogene Therapeutics, Inc. · Aug 12
Press Release Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China Aligos Therapeutics · Aug 12
Press Release Hongli Group Inc. Announces Compliance with Nasdaq Minimum Bid Price Requirement Hongli Group Inc. · Aug 12